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SUMMARY 
Systems-level identification and analysis of cellular circuits in the brain will require the 
development of whole-brain imaging with single-cell resolution. To this end, we 
performed comprehensive chemical screening to develop a whole-brain clearing and 
imaging method, termed CUBIC (Clear, Unobstructed Brain Imaging Cocktails and 
Computational Analysis). CUBIC is a simple and efficient method involving the 
immersion of brain samples in chemical mixtures containing aminoalcohols which 
enables rapid whole-brain imaging with single-photon excitation microscopy. CUBIC 
is applicable to multi-color imaging of fluorescent proteins or immunostained samples 
in adult brains, and is scalable from a primate brain to subcellular structures. We also 
developed a whole-brain cell-nuclear counterstaining protocol and a computational 
image analysis pipeline which, together with CUBIC reagents, enable the 
visualization and quantification of neural activities induced by environmental 
stimulation. CUBIC enables time-course expression profiling of whole adult brains 
with single-cell resolution. 
 
HIGHLIGHTS 
! Simple and efficient brain-clearing reagents and image informatics were 
developed. 
! CUBIC is applicable to imaging of fluorescent proteins in adult brains and 
3D-IHC. 
! The CUBIC method is scalable from a primate brain to subcellular structures. 
! CUBIC enables whole-brain imaging with single-cell resolution. 
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INTRODUCTION 
Whole-brain imaging with single-cell resolution is one of the most important 
challenges in neuroscience, since it is required for system-level identification and 
analysis (Kitano, 2002) of cellular circuits in the brain. Various cross-sectional 
tomography methods have been developed to obtain high-resolution images 
throughout the brain. Such section-based methods require expensive, specialized 
equipment, and the detailed structure between sections can be lost during sample 
processing (Gong et al., 2013; Li et al., 2010). Alternatively, brain transparentizing 
and clearing techniques, combined with rapid three-dimensional (3D) imaging using 
single-photon excitation microscopy, such as light sheet fluorescence microscopy 
(LSFM), or specific plane illumination microscopy (SPIM), can enable the study of 
systems from cells to organisms, such as cellular behaviors in developing embryos 
and neural circuits in the adult brain (Dodt et al., 2007; Hagerling et al., 2013; Tomer 
et al., 2011). Such studies require a highly transparent sample for both illumination 
and detection. 
Transparency is achieved by minimizing the light scattered by an object. Light 
is scattered at the boundary between materials with different refractive indices (RIs). 
Because lipids are a major source of light scattering in the fixed brain, the removal of 
lipids and/or adjustment of the RI difference between lipids and the surrounding areas 
are potential approaches for increasing brain sample transparency. In an early trial of 
whole-brain imaging with macrozoom LSFM (Dodt et al., 2007), the brain tissue was 
cleared with BABB, a mixture of benzyl alcohol and benzyl benzoate. Because of 
BABB’s hydrophobicity and because its high RI (1.56) (Becker et al., 2012) matched 
that of the fixed tissue, the sample was markedly cleared and suitable for observation 
with LSFM. Unfortunately, the clearing medium caused the rapid quenching of 
fluorescent signals. Although other organic chemical-based mixtures, such as 
tetrahydrofuran (THF) and dibenzyl ether (DBE) (Becker et al., 2012), performed 
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somewhat better, some frequently used fluorescent proteins such as yellow 
fluorescent protein (YFP) were still quenched (Erturk et al., 2012).  
A hydrophilic chemical mixture called Scale was developed to clear brain 
samples (Hama et al., 2011). This urea-based reagent reduced quenching and the 
resulting sample was suitable for both single-photon and multi-photon-based 3D 
tissue observation. Other issues, including relatively long sample treatment periods 
(weeks or months) and tissue swelling were resolved by the development of another 
clearing reagent, SeeDB, which renders brain samples transparent within a few days 
by adjusting RI differences between the sample lipids and the surrounding tissue (Ke 
et al., 2013). SeeDB, a hydrophilic reagent lacking detergents or denaturation agents, 
preserves detailed structures as well as fluorescence signals. The remaining issue 
was that such simple hydrophilic reagents do not render whole-brain samples 
transparent enough for single-photon-based rapid whole-brain imaging. CLARITY, a 
recently reported technique for brain clearing (Chung et al., 2013), rendered brain 
samples transparent by aggressively removing lipids using electrophoresis. The 
resulting sample was highly transparent and suitable for LSFM imaging; however, use 
of a specialized electrophoresis device with a narrow range of optimal parameters 
makes parallelization and comparison among different samples difficult. Thus, 
although previous protocols have addressed some of the issues required for the 
efficient clearance of brain samples, an improved protocol was still required for 
whole-brain imaging with single-cell resolution. 
The anatomical annotation of images is also critical. In conventional human 
brain imaging techniques such as computed tomography (CT) (Cormack, 1973), 
magnetic resonance imaging (MRI) (Lauterbur, 1973), and functional magnetic 
resonance imaging (fMRI) (Ogawa et al., 1990), anatomical annotation consists of 
two steps: 1) acquisition of whole-brain structural and specific signal (or functional) 
images, and 2) computational analysis of these images. For example, fMRI, which 
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visualizes neural activity, is almost always accompanied by MRI, which acquires a 
structural image of the whole brain. This image is then used for image registration 
and alignment to a standard whole-brain image (“reference brain”), so that signal 
images can be compared across individuals. Because computational image analysis 
is so essential, informatics tools have been developed and implemented to facilitate 
this process in conventional human brain imaging (Avants et al., 2011). However, this 
kind of computational image analysis is rare for fluorescence imaging of whole 
mammalian brains, due to the lack of whole-tissue histological counterstaining of cell 
nuclei which can be used for anatomical orientation. 3D images acquired with 
sectional tomography or tissue-clearing protocols provide information on 
fluorescently-labeled cells, but not on the overall shape and characteristic anatomical 
structures that are required for the registration and alignment steps. Even in a trial in 
which the image registration step was successful, manual determination of landmark 
structures was necessary (Gong et al., 2013). The larger number of images 
generated in time-course experiments makes the need for automated processing 
even more acute. Thus, efficient anatomical annotation will be required for 
whole-brain imaging with single-cell resolution. 
We have developed a simple, efficient, and scalable brain-clearing method 
and computational analysis pipeline, CUBIC (Clear, Unobstructed Brain Imaging 
Cocktails and Computational Analysis), that enables rapid whole-brain imaging with 
single-photon excitation microscopy. CUBIC can be applied to whole-brain imaging of 
various fluorescent proteins and 3D imaging of immunostained adult brain samples. 
CUBIC is scalable from primate brain imaging to subcellular structures such as axons 
and dendritic spines. In order to facilitate inter-individual comparisons, we have also 
developed an anatomical annotation method using a whole-brain cell-nuclear 
counterstaining protocol and a computational image analysis pipeline. CUBIC 
enables the time-course expression profiling of adult whole brains with single-cell 
resolution. 
7 
 
 
RESULTS 
Development of CUBIC reagents by comprehensive chemical screening 
To develop a simple, efficient, and scalable tissue-clearing protocol for whole-brain 
imaging, we started by re-screening the chemical components of the hydrophilic 
brain-clearing solution ScaleA2 (Hama et al., 2011). We started with this protocol 
because of its ease and its ability to preserve fluorescent signals. We considered 40 
chemicals, including polyhydric alcohols, detergents, and hydrophilic small molecules 
(Table S1), corresponding to the components of the ScaleA2 solution: glycerol, Triton 
X-100 and urea. To evaluate the clearing efficiency of these chemicals, we first 
sought to improve the experimental throughput of clearing measurements. In a typical 
evaluation procedure, we first fix, isolate, and immerse a whole mouse brain in one 
chemical mixture, and then evaluate the clearing efficiency of the chemical by 
measuring the transmittance of the fixed, cleared whole brain. For a more efficient 
evaluation protocol, we exchanged the order of the fixation and isolation steps and 
introduced a homogenization step, so that many chemicals can be tested using only 
one mouse brain (Figure 1A and EXTENDED EXPERIMENTAL PROCEDURES). 
This “solubilization” assay using a homogenized suspension instead of a whole brain 
enabled the reproducible, quantitative, and comprehensive evaluation of chemicals 
for their ability to dissolve brain tissue (Figure 1B). We also evaluated the quenching 
effect of each chemical on EGFP fluorescence in this first chemical screening (Figure 
1C). We noted that a series of aminoalcohols (#4, #8, #9, #10, #15, #16, #17) showed 
considerable brain tissue solubilizing activity, whereas polyhydric alcohols without 
amino groups (#1, #2, #3, #5, #12, #18, #19, #20) exhibited much less activity 
(Figure 1B and Table S1). This may indicate that the cationic amino group 
contributes to solvating anionic phospholipids, the most abundant lipids in the brain. 
In addition, basic aminoalcohols preserved and even enhanced EGFP fluorescent 
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signals, while some weakly acidic amine-free alcohols (#1, #2, #3, #11) quenched the 
fluorescence (Figure 1C and Table S1). Many fluorescent proteins, such as EGFP, 
EYFP, and mCherry, contain a phenolate chromophore which is highly pH sensitive, 
resulting in increased fluorescence intensity with increasing pH (until the protein 
denatures) (Kneen et al., 1998). In a highly concentrated aqueous medium without 
buffering ability, basic aminoalcohols were therefore more suitable clearing agents 
than other weakly acidic or neutral alcohols. After a second chemical screening 
(Figure 1D and 1E), our cocktail finally included 
N,N,N',N'-tetrakis(2-hydroxypropyl)ethylenediamine (#10), Triton X-100 (#25), and 
urea (#36) (Figure S1B). We refer to this first CUBIC reagent as ScaleCUBIC-1 
(hereafter denoted as reagent-1). We used the words “Scale” and “CUBIC” because 
this reagent is based on urea (Scale) and aminoalcohols (CUBIC), respectively. 
Reagent-1 treatment of the whole adult mouse brain resulted in a highly 
transparent brain (Figure 2A and 2B). The lipid-rich white matter was not completely 
cleared, possibly due to incomplete lipid removal and unmatched RIs between the 
tissue and solution. ScaleCUBIC-2 (hereafter denoted as reagent-2) was developed 
by modifying the reagent-1 recipe in a third chemical screening (Figure S1A). 
Addition of a high concentration of sucrose instead of glycerol increased the reagent 
RI [from 1.45-1.46 for glycerol-based reagent-2 to 1.48-1.49 for sucrose-based 
reagent-2, which is similar to the RI of SeeDB (RI = 1.49) (Ke et al., 2013)] so that it 
matched the tissue RI and increased the transmittance (Figure S1A). Replacing 
chemical #10 with 2,2',2''-nitrilotriethanol (#16) also reproducibly increased the 
transmittance (Figure S1A), motivating its inclusion in the final version of reagent-2 
(Figure 2A and S1B). As expected, reagent-2 enhanced the optical clearance of 
lipid-rich regions deeper in the brain (Figure 2A). 
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CUBIC is a simple and efficient procedure 
As summarized in Figure 2A, the CUBIC protocol involves a series of immersion 
steps followed by a washing step. The CUBIC brain samples were sufficiently 
transparent for adult whole-brain imaging. The sample was slightly swollen by 
reagent-1 treatment, but returned to its original size following reagent-2 treatment. In 
addition, CUBIC-based clearing can be used to clear an acrylamide gel-embedded 
sample prepared according to the CLARITY protocol (Chung et al., 2013), addressing 
concerns about destruction of detailed anatomical structures and protein loss (Figure 
S1C). 
Sample clearing with CUBIC reagents required two weeks for completion, 
comparable to CLARITY (approximately 10 days) (Chung et al., 2013) and faster than 
ScaleA2 (weeks) and ScaleU2 (months) (Hama et al., 2011). Although clearing with 
3DISCO can be completed in 5 days, fluorescence signals are quenched within a few 
days of preparation (Erturk et al., 2012). To evaluate the quenching effect of CUBIC, 
we next incubated various recombinant fluorescent proteins with reagent-1, 
reagent-2, or PBS for 24 h or 7 days (Figure 2C). The fluorescence of all the tested 
proteins, even EYFP, the most sensitive, remained high after the 7-day incubation. 
The CUBIC protocol achieved comparable transparency to other recently developed 
methods in a reasonable time, with minimal quenching of fluorescence signals. 
Notably, the red fluorescent proteins mCherry and mKate2 also showed minimal 
quenching. Given that red light transmits through tissues more efficiently than shorter 
wavelength light (Figure 2B), these proteins are very suitable as labeling tools for 
use with the CUBIC protocol. 
To confirm that CUBIC samples can be used for deep brain imaging, we 
performed two-photon imaging of a Thy1-YFP-H Transgenic (Tg) mouse brain (Feng 
et al., 2000) with an objective lens optimized for use with SCALEVIEW-A2 (working 
distance 8 mm, optimized for RI = 1.38) (Figure 2D). We treated a hemisphere with 
reagent-1 for 3 days and acquired a Z-stack image. Treatment with reagent-1 alone 
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was sufficient for deep brain imaging (up to ~4 mm) with two-photon excitation 
microscopy (Figure 2D). The accelerated clearing obtained with reagent-1 enabled 
substantially deep brain imaging up to ~4 mm, while SCALEVIEW-A2-treated 
samples became transparent more slowly (Figure S2). 
 
CUBIC enables rapid, high-performance, whole-brain imaging with LSFM 
The high transparency of CUBIC samples and the two-photon imaging results 
prompted us to perform whole-brain imaging with single-photon excitation microscopy 
techniques such as LSFM. Previous reports have used confocal- or 
multi-photon-based imaging methods (Chung et al., 2013; Ke et al., 2013), in which 
image tiling and data acquisition time (days for a single brain) were significant 
challenges. LSFM, which enables rapid whole-brain imaging, was used in a previous 
study using BABB (Dodt et al., 2007), although fluorescence signal loss over time 
was a problem. We first set up an optimized macrozoom microscope combined with a 
light-sheet illuminator (LaVision Ultramicroscope) (Figure S3A) so that an entire 
horizontal section of a mouse brain can be acquired in a single plane with sub-cellular 
resolution (theoretical X-Y resolution in the acquired image is 4.7 µm). For rapid 
whole-brain imaging, we generated a knock-in mouse strain expressing three tandem 
repeats of mKate2 with a nuclear localization signal, under control of the CAG 
promoter (Niwa et al., 1991) from the ROSA26 locus. We used mKate2 because of its 
signal intensity, photostability and rapid protein maturation (Chudakov et al., 2010), 
as well as its resistance to fluorescence quenching by CUBIC reagents (Figure 2C). 
We then collected Z-stack images of the horizontal section (Supplemental 
movie S1) of a CUBIC whole brain from two directions (dorsal to ventral, D-V, and 
ventral to dorsal, V-D). With our current microscope setup, imaging took 30 min to 1 h 
per brain/color/direction. The reconstituted 3D whole-brain image of the mKate2 
knock-in mouse (Figure 3A and S3B) and its virtual coronal sections (Figure 3B) 
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enabled the 3D visualization of spatial gene expression patterns and the examination 
of detailed internal structures. Furthermore, we confirmed that background 
fluorescence in CUBIC samples is low enough not to impair visualization of the 
fluorescent signal from mKate2 in the overall brain image data (Figure 3F – I and 
EXTENDED EXPERIMENTAL PROCEDURES). 
 
CUBIC is applicable to the whole-brain imaging of various fluorescent proteins 
Our successful imaging using mKate2 led us to test other fluorescent proteins, 
including mCherry, EGFP, and YFP. We performed similar whole-brain imaging with 
CUBIC adult whole brains from three mouse strains: an mCherry-fused Histone-2B 
expressing strain [R26-H2B-mCherry (CDB0239K), Figure 3C and S3C] (Abe et al., 
2011), an EGFP-fused Histone-2B expressing strain [R26-H2B-EGFP (CDB0238K), 
Figure 3D and S3D] (Abe et al., 2011), and a Thy1-YFP-H transgenic strain (Figure 
3E and S3E). By comparing the reconstituted sections of these samples, spatial gene 
expression patterns and their differences across samples could be easily traced. For 
example, we compared two knock-in strains in which the gene was inserted into the 
same ROSA26 locus, but regulated by different promoters; the gene for mKate2 was 
regulated by the CAG promoter, and for mCherry by the endogenous ROSA26 
promoter. The whole-brain image showed expression differences in regions such as 
the thalamus, hypothalamus, midbrain, granular layer of the cerebellum, and 
ventricular choroid plexus (Figure S3F and S3G). These results show that various 
fluorescent proteins can be used for rapid and high-performance whole-brain imaging 
with the CUBIC protocol. 
 
CUBIC is applicable to adult-brain imaging of 3D-immunostained samples 
Given that CUBIC samples were highly permeabilized by lipid removal, we predicted 
that the CUBIC protocol would be useful for the immunostaining of large blocks of 
12 
 
brain tissue, a potential improvement over sectional staining. We performed 
3D-immunohistochemistry (3D-IHC) using a brain block containing the hypothalamus 
region (Figure 4A). The block was subjected to reagent-1 treatment, followed by 
3D-IHC with antibodies to neuropeptides expressed in the suprachiasmatic nucleus 
(SCN), the central clock of the mammalian circadian system. We used antibodies for 
Copeptin [a peptide cleaved from the common precursor of arginine vasopressin 
(AVP)] (Land et al., 1982) and for vasoactive intestinal peptide (VIP) to label the AVP 
and VIP neurons in the nucleus. After immunostaining, the block was treated with 
reagent-2 for further clearing, and the resulting sample was observed with an inverted 
single-photon confocal microscope. We imaged a horizontal plane of the SCN and 
paraventricular nucleus (PVN) regions of the hypothalamus from the bottom of the 
brain. The immunostained signals were detected at a depth of over 750 µm (from the 
bottom of the brain to the dorsal area of the PVN in the hypothalamus) and were 
visualized as a 3D reconstituted image (Figure 4B and Supplemental movie S2). In 
the acquired horizontal images, the cell bodies and fibers of the two types of neurons 
were clearly visible (Figure 4C). High resolution images were also included (Figure 
S4C). Abrahamson and Moore have demonstrated that a large number of 
VIP-positive soma were densely packed in the ventral area of the SCN and 
AVP-positive soma were localized in the dorsomedial and ventrolateral area of the 
SCN and dorsally distributed even around the paraventricular nucleus (Abrahamson 
and Moore, 2001). The ventral image at a depth of ~45 µm (including the most ventral 
area of the SCN) displayed extensive VIP-positive soma signals in the left panel of 
Figure S4C. The middle image at a depth of ~65 µm (including the more dorsal area 
of the SCN) exhibited AVP-positive soma and VIP-positive fibers in the middle panel 
of Figure S4C. The dorsal image at a depth of ~780 µm (including the paraventricular 
nucleus) included sparse AVP-positive soma in the right panel of Figure S4C. 
Therefore, previously reported spatial distributions of AVP- and VIP-positive soma 
and fibers were clearly recapitulated by CUBIC-based 3D IHC. 
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We further applied 3D-IHC analysis to the SCN of both wild-type (WT) and a 
Cry1–/–, Cry2–/– clock gene double-knockout strain (van der Horst et al., 1999), 
sacrificed at different circadian times (CT). For these samples, nuclear 
counterstaining with SYTO 16, a cell-permeable green-fluorescent nucleic acid stain, 
was performed during the reagent-1 treatment. Plane images at different depths 
(Figure 4D and S4A) and reconstituted 3D images (Supplemental movies S3 and 
S4) showed CT-dependent differences in the staining patterns of these two 
neuropeptides. The most striking difference was that the fibers in the dorsal region of 
the SCN were more strongly stained at CT0 than at other circadian times. This 
tendency was reproduced in an independent set of experiments (Figure S4A) and 
well as in animals housed under light-dark conditions (Figure S4B). These 
differences were not observed in images of the Cry1–/–, Cry2–/– strain captured at CT0 
and CT12 (Figure 4D and S4A), suggesting that the observed immunostaining 
differences in the AVP and VIP neurons were dependent on the circadian clock. The 
CUBIC protocol is highly applicable to the 3D imaging of immunostained adult-brain 
blocks. 
 
CUBIC is scalable from subcellular structures to a primate brain 
In addition to the efficiency of the CUBIC protocol, its scalability is also important for a 
wide range of applications. One potential application of a brain-clearing protocol is to 
trace neural connections at the axon or synapse level. We therefore tested whether 
detailed cell structures such as axons and spines were preserved in CUBIC samples. 
We used Thy1-YFP-H transgenic mice, in which neuronal subcellular structures, 
including somata, axons, and dendritic spines, can be labeled and visualized by YFP 
fluorescence (Feng et al., 2000). A magnified view of a CUBIC brain sample from the 
Thy1-YFP-H transgenic mouse revealed that the axons and somata of neurons were 
well preserved (Figure S5A, the pontine-medullary region in the LSFM image is 
shown). A single axon was labeled and visualized without any breaks, making its 
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trajectory easily traceable. In addition, the dendritic spines in the cerebral cortex of 
the same strain were clearly observed by two-photon microscopy (Figure S5B). 
Furthermore, proteins in the spine were also preserved in the CUBIC sample by 
immunostaining with an antibody against Synapsin-I, a phosphoprotein associated 
with synaptic vesicles in neural synapses (Navone et al., 1984) (Figure S5C). 
Synaptic proteins were preserved in the CUBIC samples, suggesting that CUBIC is 
scalable to subcellular structure imaging. 
Another potential application for a brain-clearing protocol is in primate 
whole-brain imaging. The marmoset is becoming an increasingly popular primate 
model organism in neuroscience because of its potential for genetic engineering 
(Sasaki et al., 2009). We tested whether the CUBIC protocol is applicable to 
marmoset whole-brain fluorescence imaging with nuclear counterstaining. A 
postnatal-day-3 marmoset brain has approximately 10 times the volume of an adult 
mouse brain (Figure 5A). CUBIC treatment with SYTO 16 staining of the hemisphere 
from a 3-day-old marmoset resulted in clearing comparable to that achieved with the 
mouse brain (a hemisphere was used instead of a whole marmoset brain due to the 
size limitation of the microscope stage used in this study, Figure 5B). The acquired 
raw images were subjected to 3D image reconstitution to generate a 
volume-rendering image (Figure 5C and 5D) and reconstituted sections (Figure 5E). 
The reconstituted image clearly depicts general and detailed structures of the 
marmoset brain such as vessels and layers of the cerebral cortex (Figure 5C – E and 
Supplemental movie S5). These results suggest that the CUBIC protocol is scalable 
to larger tissues, indicating its potential application to various animals including 
primates. Together, the CUBIC protocol is scalable from sub-cellular structures to a 
primate brain, a feature that will support wide-ranging applications in neuroscience. 
 
Whole-brain nuclear counterstaining and computational image analysis in 
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CUBIC enable the visualization of neural activities induced by environmental 
stimulation with single-cell resolution 
Another challenge for establishing whole-brain imaging with single-cell resolution is 
the development of anatomical annotation. For this purpose, we used Arc-dVenus 
transgenic mice, in which an unstable Venus protein is expressed under the control of 
a neural activation marker gene, Arc (Eguchi and Yamaguchi, 2009). Arc-dVenus 
transgenic mice were housed under constant dark conditions for about 2.5 days and 
then exposed to constant light at CT2.5, followed by fixation and collection of their 
brains (Figure 6A). As previously reported, light-dependent neural activation was 
observed with fluorescent stereomicroscopy, showing increased Venus signals in the 
visual area of the cortex in a light-exposed brain [Figure S6A, Light+ (1)], compared 
with a control brain (Figure S6A, Light-). 
Since anatomical annotation requires the acquisition of whole-brain structural 
images, we performed nuclear counterstaining with propidium iodide (PI) to acquire 
whole-brain structural images in the red channel. The brain samples were subjected 
to CUBIC treatment with PI counterstaining, and the resulting samples were analyzed 
by whole-brain imaging with LSFM. The reconstituted 3D images clearly revealed 
light-responsive neurons, such as those in the visual area (Vi) (Figure 6B and 6C, 
Supplemental movies S6 and S7). Individual neurons were clearly visible, 
suggesting that the whole-brain image achieved single-cell resolution. Several 
additional brain regions including the motor area (Mo), the anterior cingulate area 
(Ac), the orbital area, and subcortical areas in the forebrain [such as the claustrum 
and endopiriform nucleus (Cl/Ep)], also exhibited increased Venus signals in the 
light-exposed brain (Figure 6B), compared to the control brain (Figure 6C). These 
areas are known to be connected to each other and to respond to several sensory 
stimuli (Miller and Vogt, 1984; Reep et al., 1996; Sloniewski et al., 1986). This result 
was reproduced in another light-exposed brain [Light+ (2) in Figure S6A and S6B]. 
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We next focused on the development of a computational image analysis 
pipeline (“CUBIC informatics”, Figure 7A). We first combined whole-brain images of 
the same brain that had been captured from two opposite directions 
(dorsal-to-ventral: D-V, and ventral-to-dorsal: V-D) (Figure S7A and S7B). This was 
necessary because whole-brain images captured from the dorsal-to-ventral direction 
(D-V images) were clear on the dorsal side but blurred on the ventral side, and vice 
versa (Figure S7C and S7E, V-D image and D-V image). To combine the two 
images, we first aligned them (Figure S7A), and then generated a single whole-brain 
image by considering the sharpness of each horizontal plane (Figure S7D). The 
blurred areas were compensated for in the combined image (Figure S7E, combined 
image), which was used for subsequent computational analysis. 
Applying this pipeline to Arc-dVenus transgenic mouse brains, we aligned the 
combined PI image of an internal reference brain (Light-) to a reference brain (Figure 
7B), aligned the PI images captured from the Light+ and Light- brains (Figure 7C), 
and directly compared the dVenus fluorescence signals of these brains by overlaying 
their aligned images (Figure 7D). Subtraction of the signal intensities clearly showed 
the brain regions stimulated by light (Figure 7E). These regions included areas 
identified in Figure 6B and S6B, but with improved clarity due to the sharper 
combined image. The CUBIC protocol combined with CUBIC informatics enables 
gene expression profiling of adult whole brains.
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DISCUSSION 
CUBIC is a simple, efficient, and scalable protocol of wide applicability 
The CUBIC protocol appears to have reconciled some of the seemingly incompatible 
demands of previous methods. First, it is simple in that it requires only the immersion 
of tissue in two reagents for relatively short periods (Figure 2). Simplicity is 
advantageous for multi-sample imaging. The water-based Scale and SeeDB methods 
also have simple protocols, although the resulting sample transparency is insufficient 
for rapid whole-brain imaging of the adult brain. 3DISCO and CLARITY produce 
highly transparentized brain samples, but require careful handling of reagents or 
specialized devices. CLARITY also requires expensive clearing reagents such as 
FocusClearTM for final clearing before imaging. In contrast, CUBIC produced a highly 
transparent brain specimen at lower cost (Table S1) and using non-toxic 
water-soluble chemicals. Second, the CUBIC protocol can be used with many 
different types of fluorescent proteins (Figure 3 and 6) and to compare multiple 
samples by 3D-IHC (Figure 4). This efficient and highly reproducible method also 
enabled time-course expression profiling with single-cell resolution. Third, the CUBIC 
protocol is scalable, as it achieved transparentization of a larger primate brain 
(Figure 5) while preserving detailed subcellular structures such as the axons and 
spines of neurons (Figure S5). CUBIC reagents can also be used to clear 
acrylamide-gel-embedded samples prepared according to the CLARITY protocol 
(Chung et al., 2013), if necessary (Figure S1C). The CUBIC protocol and reagents 
have the potential to be modified or optimized based on specific sample or 
experimental needs. For example, our preliminary tests revealed that it was possible 
to prepare partially cleared samples for two-photon microscopy by using a 
low-stringency version of reagent-1 for several hours. 
Rapid whole-brain imaging cannot deliver its maximum benefit without 
imaging devices optimized for the cleared tissues. Since LSFM showed potential for 
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high-performance whole-brain imaging early in its development (Dodt et al., 2007), 
we optimized LSFM for lower spherical aberration (Figure S3A) and acquired 25 
whole-brain images, most of which were collected within a few days. Our optimized 
LSFM setup could capture seamless whole-brain images with relatively high 
resolution. This is particularly important for comparing multiple 3D whole-brain 
images with single-cell resolution, because the assembly of numerous plane images 
still has issues such as unavoidable errors of mechanical stage accuracy, the need 
for additional calculations to correct for optical distortion and rotation for reconstitution, 
or the accumulation of huge datasets (Emmenlauer et al., 2009; Preibisch et al., 
2009). Improvements in illumination (Kalchmair et al., 2010; Leischner et al., 2009) 
and image processing (Mertz and Kim, 2010) and technological sharing through open 
platforms such as OpenSPIM (Pitrone et al., 2013) will also advance the speed and 
resolution of whole-brain imaging. In addition, the development of an RI-adjusted 
objective lens will further facilitate the high-resolution imaging of CUBIC samples. 
 
CUBIC enables whole-brain imaging with single-cell resolution 
In this study, we conducted whole-brain nuclear counterstaining using SYTO 16 or PI, 
and successfully acquired structural information with anatomical annotation, which is 
important for whole-brain imaging with single-cell resolution (Figure 6B, 6C, and 7). 
Since CUBIC preserves global anatomical structure in brain specimens, the 
anatomical annotation was highly reproducible; for example, the PI images of two 
different brains in Light+ and Light- mice show substantial overlap (Figure 7C). In 
addition, the computationally standardized PI image mapped well to a “reference” 
brain such as that in the Waxholm Space atlas (Figure 7B), enabling reliable 
annotation of the observed signals. Imaging can be further improved by combining 
two whole-brain images of the same brain captured from opposite directions (D-V and 
V-D). Using an edge detection algorithm, it was possible to automatically define a 
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weighted sum between images from these two directions and obtain a combined 
image that was sharp throughout the brain (Figure 7 and S7). This improved both the 
alignment to the reference structures and the clarity of the fluorescent signal images. 
The CUBIC protocol, together with CUBIC informatics, enabled the accurate 
comparison of multiple whole-brain images. This high-throughput method enables 
efficient handling of a large number of brain samples. This is particularly useful when 
investigating dynamic biological phenomena. 
To realize system-level identification and analysis of cellular circuits in the 
brain, it will be important to combine high-throughput whole-brain imaging with other 
key technologies. One interesting synergy may exist with CRISPR/Cas-mediated 
genetically engineered mice, in which knock-in animals harboring neural-activity 
reporters (e.g. Arc-dVenus) can be generated within a single generation (Yang et al., 
2013). The comprehensive description of phenotype-correlated cells using such 
knock-in mice is an important step in determining the cellular circuits underlying 
biological phenomena of interest. If neural activity modifiers such as tetanus toxin 
(Yamamoto et al., 2003), Allatostatin (Tan et al., 2006), or DREADDs and PSAMs 
(Armbruster et al., 2007; Magnus et al., 2011) could be selectively introduced and 
expressed in a limited population of cells together with a fluorescent protein marker, 
phenotype-responsive cells could be functionally identified by whole-brain imaging. 
The combination of neural activity modifiers (expressed in a limited neural population) 
and neural activity reporters (expressed throughout the brain) with CUBIC could 
enable the identification and analysis of functional connectivity at the whole-brain 
level. In addition, anterograde and retrograde neural tracers, when used with the 
CUBIC protocol, could also provide direct connectivity information at the whole-brain 
level (Wickersham et al., 2007). When combined with other emerging technologies, 
CUBIC should contribute to the system-level identification and analysis of cellular 
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circuits in the whole brain and probably in the whole body. New research field such as 
whole-brain cell profiling or whole-body cell profiling (WBC profiling) lies ahead. 
21 
 
EXPERIMENTAL PROCEDURES 
Also see EXTENDED EXPERIMENTAL PROCEDURES for details. 
The CUBIC protocol 
ScaleCUBIC-1 (reagent-1) was prepared as a mixture of 25 wt% urea (Nacalai 
Tesque Inc., 35904-45, Japan), 25 wt% 
N,N,N',N'-tetrakis(2-hydroxypropyl)ethylenediamine (Tokyo Chemical Industry CO., 
LTD., T0781, Japan), and 15 wt% polyethylene glycol mono-p-isooctylphenyl 
ether/Triton X-100 (Nacalai Tesque Inc., 25987-85, Japan). ScaleCUBIC-2 
(reagent-2) was prepared as a mixture of 50 wt% sucrose (Nacalai Tesque Inc., 
30403-55, Japan), 25 wt% urea, 10 wt% 2,2',2''-nitrilotriethanol (Wako Pure Chemical 
Industries Ltd., 145-05605, Japan), and 0.1% (v/v) Triton X-100. For whole-brain 
clearing, each fixed brain was immersed in 10 g of reagent-1 at 37°C with gentle 
shaking for 3 days, after which the solution was exchanged and the sample immersed 
in the same volume of fresh reagent-1 for an additional 3 to 4 days. The treated brain 
was washed with PBS several times at room temperature while gently shaking, 
immersed in 20% (w/v) sucrose in PBS, degassed, and immersed in reagent-2 (10 g 
per brain) for 3 to 7 days. After imaging, the sample was again washed with PBS, 
immersed in 20% (w/v) sucrose in PBS, and stored in O.C.T. compound at –80°C. 
 
Microscopy 
Whole-brain fluorescence images were acquired with an LSFM (Ultramicroscope, 
LaVision BioTec, Germany) using 488 nm and 588 nm lasers, an sCMOS camera, 
and a macrozoom microscope (Figure S3A). Each plane was illuminated from both 
the right and left side of the sample, and a merged image was saved. Immunostained 
SCN and cerebral cortex images were acquired with an inverted confocal microscope 
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(Leica TCS SP8 or Carl Zeiss LSM700). Images of Arc-dVenus Tg brains (Figure 
S6A) were captured with a fluorescence stereomicroscope using the same settings 
as previously described (Eguchi and Yamaguchi, 2009). Two-photon imaging was 
performed using an upright multiphoton microscope (Olympus FV1000, BX61WI or 
Carl Zeiss LSM7MP). 
 
Image data processing and the CUBIC informatics 
All raw imaging data were collected in a lossless TIFF format. 3D-rendered images 
were visualized and captured with Imaris software (Version 7.6.4, Bitplane). 3D brain 
images in the NIfTI-1 format are constructed with Convert3D from ITK-SNAP 
(Yushkevich et al., 2006). The combination of two images acquired from opposite 
directions into a single composite 3D image ensured the optimal sharpness of the 3D 
brain images. The reference atlas used in our analysis was the Waxholm Space Atlas 
(Johnson et al., 2010). To facilitate analysis across samples, whole-brain images 
were registered and aligned to reference structures. We aligned images by pairs, in 
which one image corresponded to the structural information (obtained via nuclear 
staining) and the other to the fluorescent signal channel. Thus, the analysis of each 
pair required two steps: (i) registration of the structural information to a reference, and 
(ii) alignment of both images by applying the transformation (calculated during 
registration) to both the structural image and the fluorescent image (Figure 7A). For 
image registration, we used ANTs (Advanced Normalization Tools), which has proved 
successful in resolving a number of image registration issues (Murphy et al., 2011).
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FIGURE LEGENDS 
Figure 1. Development of CUBIC reagents by comprehensive chemical 
screening 
(A) Method for screening chemicals for brain-solubilizing activity using a fixed brain 
suspension. Turbidity of the suspension was quantitatively determined with an 
absorptiometer, and expressed as an OD600 value. See also EXTENDED 
EXPERIMENTAL PROCEDURES and Table S1. (B) Solubilization assay. The fixed 
brain suspension was mixed and incubated with 10 wt% aqueous solutions of 
candidate chemicals. After 24 h, the mixtures were subjected to OD600 measurement. 
(C) EGFP quenching assay. Recombinant EGFP was incubated in 10 wt% aqueous 
solutions of candidate chemicals for 12 h, after which the fluorescence signals were 
measured. In B and C the data represent the average (± SD) of two independent 
measurements. Chemicals chosen for the second chemical screening in D and 
glycerol (#18) are indicated with magenta arrowheads and a green arrowhead, 
respectively. (D) Second chemical screening of candidate chemicals for reagent-1. 
The EGFP quenching assay was performed with the final recipe of reagent-1 (Figure 
S1B). Fluorescent signal intensities were measured as in C, and the average relative 
fluorescence ± SD of two independent measurements is shown in the graph. (E) 
Effect of using aminoalcohols instead of glycerol in reagent-1. From the results in D, 
we chose aminoalcohols (#10, #16, #17), Triton X-100 (#25) and urea (#36) for 
further evaluation. Glycerol (#18) was also tested as a Scale-based mixture as in D. 
Fixed mouse hemispheres were subjected to clearing with the indicated solutions for 
3 days followed by measurement of transmittance (360-740 nm). The transmittance 
data are shown as relative transmittance, normalized to the blank, defined as 100. 
The values in the graph represent the average ± SEM from two independent samples. 
Note that some of the values exceeded 100, possibly due to the difference in the RI of 
the sample and the surrounding air (see EXTENDED EXPERIMENTAL 
PROCEDURES). See also Figure S1. 
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Figure 2. CUBIC, a simple and efficient whole-brain clearing protocol 
(A) CUBIC protocol. A fixed whole brain (from a 6 month-old mouse) was treated with 
reagent-1 to remove lipid components for up to 7 days, followed by washing with 
PBS. The sample was then treated with reagent-2 for 2-7 days to adjust the refractive 
indices of the tissue and reagent. Optional procedures are indicated in orange boxes: 
nuclear counterstaining during reagent-1 treatment, 3D-IHC of a reagent-1 treated 
sample, and sample storage at 4˚C or –80˚C after completion. (B) Transmission 
curves. Light transmittance (360-740 nm) of fixed whole brain (N = 3), 
reagent-1-treated whole brain (day 7, N = 4), reagent-2-treated whole brain (day 3, N 
= 3), and the corresponding reagents (N = 1, for each reagent) were measured and 
normalized to the blank. Data shown represent the average ± SEM. (C) Quenching 
test of fluorescent proteins by CUBIC reagents. The indicated recombinant 
fluorescent proteins were incubated in each reagent or PBS for 24 h or 7 days, 
followed by measurement of the fluorescent signal intensity. Data shown represent 
the average ± SD of three independent measurements. (D) Two-photon deep brain 
imaging of a reagent-1-treated Thy1-YFP-H Tg hemisphere. A single hemisphere 
was treated with the reagent-1 for 3 days at 37˚C. The resulting sample was observed 
using two-photon microscopy. See also Figure S2. 
 
Figure 3. CUBIC can be used for rapid and high-performance whole-brain 
imaging of various fluorescent proteins 
3D-reconstituted images of mouse brains expressing various fluorescent proteins 
were acquired with LSFM. A, anterior; P, posterior; R, right; L, left; D, dorsal; V, 
ventral. Ventral view is shown. (A) R26-pCAG-nuc-3×mKate2 mouse brain 
(5-week-old mouse). Images were acquired from the ventral to dorsal (V-D) direction. 
Z-stack: 10-µm step × 646 planes, with 0.28 seconds × two illuminations. (B) 
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Reconstituted coronal sections at the indicated positions (1-3) shown in A. Cc, 
cerebral cortex; Cp, caudoputamen; Th, thalamus; Hy, hypothalamus; Hp, 
hippocampus; Am, amygdala; Pu, Purkinje cell layer. (C) V-D image of a 
R26-H2B-mCherry mouse brain (6-month-old mouse). Z-stack: 10-µm step × 709 
planes, with 4 seconds × two illuminations. (D) V-D image of a R26-H2B-EGFP 
mouse brain (6-month-old mouse). Z-stack: 10-µm step × 665 planes, with 4 seconds 
× two illuminations. (E) V-D image of a Thy1-YFP-H Tg mouse brain (2-month-old 
mouse). Z-stack: 10-µm step × 696 planes, with 0.3 seconds × two illuminations. See 
also Figure S3 and Supplemental movie S1. (F) Left: raw TIFF image from plane 
322 of the R26-pCAG-nuc-3×mKate2 mouse brain. Center: false-color image 
highlighting regions with intensity below 8100 (blue), between 8100 and 35000 
(green), and over 35000 (red). In each channel, brighter colors mean higher intensity 
within the range, in the raw image. Right: processed image for plane 322, where all 
pixels whose intensity is below 8100 are set to black. (G) Low-intensity peaks 
(corresponding to background peaks) in the TIFF image histogram, shown for planes 
161, 322 and 483. (H) Background peaks (BG peak) and percentiles for the intensity 
distribution of pixels whose intensity is at least 5% higher than BG peak. (I) Ratios 
between the percentiles and the background peaks shown in H. 
 
Figure 4. CUBIC can be used for imaging of 3D-immunostained adult brain 
samples 
(A) CUBIC treatment procedure and 3D-immunohistochemistry (3D-IHC) of a 
hypothalamus block with anti-VIP and -Copeptin antibodies (1st ab) and 
Alexa-conjugated second antibodies (2nd ab). (B) 3D view of the SCN region of 
R26-H2B-EGFP mouse. Sampling was performed at zeitgeber time 12 (ZT12) under 
12 h:12 h light-dark conditions. Horizontal images were acquired from the ventral side 
with an inverted confocal microscope (Z-stack: 4.99-µm step × 173 planes). A, 
anterior side; P, posterior side; D, dorsal side; V, ventral side. Asterisks indicate 
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non-specific signals in the third ventricle and the vessels. (C) Selected horizontal 
images (Z-projection with maximum intensity, 4.99-µm step × 3 planes) from B. 
Approximate depth from the first image of the Z-stack data is indicated. (D) 3D-IHC 
results of the WT and Cry1–/–, Cry2–/– SCN, collected at different time points under 
constant dark conditions. Nuclear counterstaining with SYTO 16 was performed 
during reagent-1 treatment. Depth of the horizontal images was approximately 140 
µm on the ventral side and 290 µm on the dorsal side (Z-projection with maximum 
intensity, 1.98-µm step × 3 planes) from the most ventral plane of the SCN region. 
Strong signals for the neuropeptides were detected on the dorsal side of the WT SCN 
at CT0 of day 2 (arrowheads), which were barely detected in the Cry1–/–, Cry2–/– SCN. 
Images were acquired and processed in a similar but an optimized condition for each 
sample so that most of the stained signals were obtained in the unsaturated range of 
intensity. See also Figure S4 and Supplemental movie S2 – S4. 
 
Figure 5. CUBIC is scalable to a primate brain 
(A) Comparison of the size of an adult mouse brain and a postnatal-day-3 (P3) 
marmoset brain. (B) CUBIC treatment and SYTO 16 nuclear staining of the marmoset 
hemisphere. The images of the same marmoset hemisphere after reagent-1 and 
reagent-2 treatments are shown. (C-E) A 3D-reconstituted fluorescent image of the 
nuclear-stained marmoset hemisphere (Z-stack: 10-µm step × 900 planes, with 0.25 
seconds × two illuminations) acquired with LSFM. Magnified view of the boxed region 
in C is shown in D. A reconstituted coronal section at the indicated position in C is 
shown in E. Anatomical structures such as vessels and layers of the cerebral cortex 
can be observed in the reconstituted images. See also Figure S5 and Supplemental 
movie S5. 
 
Figure 6. Whole-brain nuclear counterstaining in CUBIC enables the 
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visualization of neural activities induced by environmental stimulation 
(A) Experimental scheme. Arc-dVenus Tg mice (11 weeks old) housed under 
constant dark (DD) conditions for about 2.5 days were then stimulated by light 
(Light+) or maintained in the dark (Light-), and sacrificed 5 h after stimulation. (B and 
C) Whole-brain images and reconstituted coronal sections (indicated positions in the 
whole brain image in B) of CUBIC brains from Light+ (1) and Light- mice, 
corresponding to Figure S6A. The brains were stained with PI (light purple), and 
two-color D-V images were acquired with LSFM (Z-stack: 10-µm step × 625 planes 
for B, and 10-µm step × 648 planes for C, with 3 seconds × two illuminations for 
Venus and with 0.3 seconds × two illuminations for PI, respectively). A region 
including the visual area is indicated by the dotted ellipse. Areas where Venus signals 
were increased in the Light+ brain are indicated in the whole-brain image and 
reconstituted coronal sections in B. Or, orbital area; Mo, motor area; Ac, anterior 
cingulate area; Ep, endopiriform nucleus; Cl, claustrum; Vi, visual area; Ss, 
somatosensory area. See also Figure S6, Supplemental movie S6 and S7. 
 
Figure 7. Computational image analysis enables gene expression profiling of 
adult whole brains 
(A) Scheme of CUBIC informatics pipeline (see Figure S7A in details). Structural 
information from a nuclear-stained image is used for registration to a reference brain 
so that a standardization matrix can be calculated. The resulting matrix is then 
applied to the corresponding signal image. Standardized images from different brains 
can be merged directly to generate a subtracted signal image. (B) Standardized PI 
image mapped to the Waxholm Space atlas, after V-D and D-V image combination 
and standardization to the reference brain. The analysis was performed using 
downscaled NIfTI-1 files and visualized with ITK-SNAP (see EXTENDED 
EXPERIMENTAL PROCEDURES; also in C-E). Ob, olfactory bulb; Cc, cerebral 
cortex; Cp, caudoputamen; Hp, hippocampus; Th, thalamus; Mb, midbrain; Po, pons; 
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Me, medulla; Cb, cerebellum; Hy, hypothalamus. (C) PI images of two different brains 
(Light+ (1), red and Light-, green) and their overlays after V-D and D-V image 
combination, sample alignment, and standardization to the reference brain. (D) 
Subtraction data of Light+ (1) and Light- dVenus images, corresponding to sections in 
B and C. (E) Subtraction data of Light+ (1) and Light- dVenus images, corresponding 
to coronal images in Figure 6B and 6C. Pink and light blue indicate regions where 
the Venus signals were stronger under Light+ and Light- conditions, respectively. 
Images were overlaid with the PI data of Light+ (1) specimen. Areas where Venus 
signals were increased in the Light+ brain are indicated as in Figure 6B. See also 
Figure S7. 
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Table S1. List of screened chemicals (Related to Figure 1A and S1) 
(Columns A–G) Three categories of chemicals were screened: 1) Polyhydric 
alcohols, 2) Detergents, and 3) Urea-like hydrophilic small molecules. (A) Chemical 
ID number used in this manuscript. (B) Chemical name. (C) CAS registry number. (D) 
Supplier, catalog number, and purchased amount of chemical (in parentheses). (E) 
Cost of purchased chemical. (F) Cost of each chemical per unit (g or mL). (G) Notes. 
 
Figure S1. Development of CUBIC reagents by comprehensive chemical screening 
(Related to Figure 1) 
(A) Development of reagent-2, a high RI version of reagent-1. Reagent-2 candidate 
solutions contained 50 wt% sucrose or glycerol, 25 wt% urea, 10 wt% of an 
aminoalcohol and 0.1% (v/v) Triton X-100. Fixed mouse hemispheres were treated 
with reagent-1 (#10/#25/#36) for 5 days, washed with PBS, and immersed in each 
reagent-2 for 24 h. The refractive indices of sucrose- or glycerol-containing reagent-2 
were 1.48-1.49 and 1.45-1.46, respectively. After the incubation of reagent-1-treated 
hemispheres with the various reagent-2 candidate solutions, transmittance (360-740 
nm) was measured as in Figure 1E. Sucrose-based solutions resulted in higher 
transmittance values than glycerol-based solutions, and 
2,2',2''-nitrilotriethanol/triethanolamine (#16) tended to clear the samples more 
reproducibly than the other tested aminoalcohols. Note that some of the values 
exceeded 100 as in Figure 1E (see Extended Experimental Procedure for the 
details). The values represent the average ± SEM. from two independent samples. 
(B) Recipes of CUBIC reagents and ScaleA2. Aminoalcohols were chosen in place of 
glycerol. We referred to the concentration of urea (#36) in ScaleA2 (4 M) for 
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determining its concentration in CUBIC reagents (25 wt%). However, it was 
calculated as wt% for ease of preparing the mixtures. Other components were added 
as much as possible, considering fluorescence signals and viscosity. (C) CUBIC 
clearing using an acrylamide-embedded brain prepared according to the CLARITY 
protocol. The reagent-1 and -2 were used to clear an acrylamide-embedded mouse 
brain (Chung et al., 2013). Although the clearing was less efficient compared to the 
results using “fix-only” samples (Figure 2A), the protocol could be applied to the 
polymer-embedded sample. 
 
Figure S2. Two-photon deep brain imaging of SCALEVIEW-A2 treated Thy1-YFP-H 
Tg hemispheres (Related to Figure 2) 
Two-photon deep brain imaging of Thy1-YFP-H Tg hemispheres, treated with 
commersially available ScaleA2 solution (SCALEVIEW-A2 from Olympus) as in the 
same condition of Figure 2D (for 3 days at 37 ̊C). The resulting sample was observed 
using two-photon microscopy as in Figure 2D. The performance of ScaleA2 in a 
Thy1-YFP-H Tg brain after treatement for 7 days is found in the Scale original paper 
(Hama et al., 2011), and recent update of Scale technology will be available at 
http://cfds.brain.riken.jp. 
 
Figure S3. Details of the CUBIC application to rapid whole-brain imaging of various 
fluorescent proteins (Related to Figure 3) 
(A) Setup of the light-sheet fluorescent microscopy (LSFM) equipment used in this 
study. (B) The R26-pCAG-nuc-3×mKate2 mouse brain (from a 5-week-old mouse) 
shown in Figure 3A and 3B. Images were acquired from the dorsal to ventral (D-V) 
direction and depicted from the ventral side in order to directly compare with Figure 3. 
Z-stack: 10-µm step × 646 planes, with 0.28 seconds × two illuminations. (C) D-V 
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image of the R26-H2B-mCherry mouse brain (from a 6-month-old mouse) shown in 
Figure 3C. Z-stack: 10-µm step × 696 planes, with 4 seconds × two illuminations. (D) 
D-V image of the R26-H2B-EGFP mouse brain (from a 6-month-old mouse) shown in 
Figure 3D. Z-stack: 10-µm step × 667 planes, with 4 seconds × two illuminations. (E) 
D-V image of the Thy1-YFP-H Tg mouse brain (from a 2-month-old mouse) shown in 
Figure 3E. Z-stack: 10-µm step × 733 planes, with 0.3 seconds × two illuminations. 
(F and G) Selected acquired horizontal images and reconstituted sagittal and coronal 
images of the R26-pCAG-nuc-3×mKate2 knock-in brain (V-D imaging) and the 
R26-H2B-mCherry knock-in brain (V-D imaging) shown in Figure 3A – 3B and 3C, 
respectively. Both of the genes were knocked into the same ROSA26 locus but were 
regulated by different promoters (the CAG promoter versus the endogenous ROSA26 
promoter). The expression patterns of these proteins were compared with the 
corresponding reconstituted sections. Areas of differential expression are indicated. 
Th, thalamus; Px, ventricular choroid plexus; Me, medulla; Gu, granular layer of 
cerebellum. A, anterior; P, posterior; R, right; L, left; D, dorsal; V, ventral. 
 
Figure S4. Reproducibility in the application of CUBIC to the adult-brain imaging of 
3D-immunostained samples (Related to Figure 4) 
(A) An independent set of 3D-IHC imaging results corresponding to Figure 4D is 
shown. WT and Cry1–/–, Cry2–/– samples were stained with antibodies to VIP and 
Copeptin. Staining of both the WT and Cry1–/–, Cry2–/– SCN (day-2, CT0) was partially 
incomplete due to a scar in the sample (indicated as “s” in the ventral images). (B) 
The R26-H2B-EGFP mice housed under 12 h:12 h light-dark conditions were 
sacrificed at the indicated zeitgeber time (ZT), and the fixed brains were subjected to 
a similar 3D-IHC analysis. Consistent with the results in Figure 4D, the dorsal fibers 
close to the third ventricle were more strongly stained at ZT0 than ZT12. In both 
panels, the depth of the horizontal images is approximately 140 µm on the ventral 
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side and 290 µm on the dorsal side (Z-projection with maximum intensity, 1.98-µm 
step × 3 planes in A and 3.76-µm step × 2 planes in B) from the most ventral plane of 
the SCN region. Strong signals of the neuropeptides detected in the dorsal side of 
SCN at CT0/ZT0 are indicated with arrowheads. (C) Enlarged 3D-IHC analysis 
images of the other R26-H2B-EGFP mice SCN (left and middle panels) and PVN 
(right panel), sacrificed at the ZT12 (Z-projection with maximum intensity, 3.76-µm 
step × 2 planes). Images were acquired and processed in a similar but an optimized 
condition for each sample so that most of the stained signals were obtained in the 
unsaturated range of intensity. 
 
Figure S5. CUBIC is scalable in its application to subcellular structure imaging 
(Related to Figure 5) 
(A) Axons in the pontine-medullary region of the Thy1-YFP-H Tg CUBIC brain sample, 
observed with LSFM. The image is a part of the Z-projection image of the V-D YFP 
channel imaging data shown in Figure S7B (Z-projection with maximum intensity, 
10-µm step × 21 planes). Py, pyramidal tract. (B) Spines in the cerebral cortex of the 
Thy1-YFP-H Tg CUBIC brain sample, observed with two-photon microscopy. The 
image is part of the Z-projection image of two-photon imaging data (Z-projection with 
maximum intensity, 0.5-µm step × 20 planes). (C) Immunostaining with a Synapsin-I 
antibody in the cerebral cortex of the Thy1-YFP-H Tg CUBIC brain sample, observed 
with confocal microscopy. Part of an original acquired image is shown. 
 
Figure S6. Whole-brain nuclear counterstaining in CUBIC enables the visualization of 
neural activities induced by environmental stimulation (Related to Figure 6) 
(A) Venus signals (green) of Arc-dVenus Tg mouse brains, which were used for 
Figure 6 and S6B, were also observed with fluorescent stereomicroscopy. A region 
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including the visual area in the cortex is indicated by a dotted ellipse, encompassing 
the area where the Venus signals appeared in Light+ brains. (B) The Light+ (2) 
Arc-dVenus Tg mouse brain was subjected to CUBIC treatment, and two-color D-V 
images were acquired with LSFM (Z-stack: 10-µm step × 633 planes) as in Figure 6B. 
Increased fluorescent signals were observed in the same regions as observed in the 
Light+ (1) brain shown in Figure 6B. 
 
Figure S7. Computational image analysis in CUBIC enables gene expression 
profiling of adult whole brains (Related to Figure 7) 
(A) Overview of computational analysis steps. For each brain, we first combined 
imaging data acquired in the ventral-to-dorsal (V-D) and dorsal-to-ventral (D-V) 
directions. To do so, we first aligned the D-V and the V-D brain images and then 
considered the sharpness of each horizontal plane to generate a single clear 3D 
image as in C–E. These samples were then aligned to an internal reference brain, 
and to a reference atlas. This was achieved by registering the image containing 
structural information, and then applying the corresponding transformation to both the 
structural and the signal image of the same brain. Finally, the aligned signal images 
were compared and contrasted using methods such as subtraction, to highlight 
differences between samples. (B) A data set consisting of reconstituted 3D images 
acquired from a single Thy1-YFP-H Tg mouse brain subjected to whole-brain nuclear 
counterstaining with PI is shown. Structural information obtained by PI staining was 
used to calculate the transformation matrix. Z-stack: 10-µm step × 722 planes for V-D 
imaging and 10-µm step × 797 planes for D-V imaging, with 0.6 seconds × two 
illuminations for YFP and with 0.15 seconds × two illuminations for PI, respectively. 
Scale bar: 1 mm. (C) Image sharpness depended on acquisition directions. The raw 
data in B were converted to a NIfTI-1 file for further analysis. We downscaled original 
image data to 25% (i.e. keeping one of every four images and changing the resolution 
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of these images from 2560×2160 to 640×540). During conversion, the same plane 
number was assigned to equivalent planes of both images. In this case, the ventral 
horizontal planes were sharper in the V-D image, while dorsal horizontal planes were 
sharper in the D-V image. The images obtained in two directions were combined to 
obtain a single clear 3D image. (D) Estimating the edge content to combine the two 
acquisition directions. A classic edge detection method is to use the Sobel operator 
(noted Ei,j here), which corresponds to a gradient estimation at pixel (i,j) of an image. 
Summing this value over all pixels of the image gives us the edge content Etot of the 
image. Plotting Etot as a function of the plane number, for the V-D and D-V images, 
confirms the observation from C. If we note these values EVD and EDV, respectively, 
we can define a unique range [n,m] where |EVD - EDV| / EVD < 0.1. Finally, the values 
for n and m are used to design a weighted sum of the V-D and D-V images (see 
EXTENDED EXPERIMENTAL PROCEDURES). (E) Combining the compensated 
V-D and D-V images from a single Thy1-YFP-H brain (NIfTI-1 file). n = 87, m = 93. 
 
Supplemental movie S1 
Acquired images and a reconstituted 3D image of the R26-pCAG-nuc-3×mKate2 
knock-in mouse brain (V-D imaging), corresponding to Figure 3A and 3B. 
 
Supplemental movie S2 
Reconstituted 3D image of the immunostained SCN of a R26-H2B-EGFP knock-in 
mouse, corresponding to Figure 4B and 4C. Views start from the dorsal side. 
 
Supplemental movie S3 
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Reconstituted 3D image of the immunostained SCN of a WT mouse at CT12 of day-1 
and CT0 of day-2 under constant dark conditions, corresponding to Figure 4D and 
S4A. Views are from the dorsal side. Z-stack: 1.98-µm step × 165 planes. 
 
Supplemental movie S4 
A reconstituted 3D image of the immunostained SCN of a Cry1–/–, Cry2–/– double 
knockout mouse at CT12 of day-1 and CT0 of day-2 under constant dark conditions, 
corresponding to Figure 4D and S4A. Views are from the dorsal side. Z-stack: 
1.98-µm step × 165 planes. 
 
Supplemental movie S5 
A reconstituted 3D image of the marmoset hemisphere stained with a nuclear staining 
reagent SYTO 16, corresponding to Figure 5C – 5E. 
 
Supplemental movie S6 
A reconstituted 3D image of the Arc-dVenus Light+ (1) brain stained with PI, 
corresponding to Figure 6B. Green, dVenus; light purple, PI. 
 
Supplemental movie S7 
A reconstituted 3D image of the Arc-dVenus light- brain stained with PI, 
corresponding to Figure 6C. Green, dVenus; light purple, PI. 
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EXTENDED EXPERIMENTAL PROCEDURES 
Mice 
The R26-pCAG-nuc-3×mKate2 knock-in mouse strain was established in our 
laboratory. A vector harboring all of the required elements, including the CAG 
promoter from pPyCAG-BstXI-IP (Niwa et al., 1991), the cDNAs encoding the nuclear 
localization signal of the SV40 Large T-antigen (PKKKRKV) and the triplicated 
mKate2 from pmKate2-C (Evrogen), the woodchuck hepatitis post-transcriptional 
regulatory element (WPRE) from pTRIPZ (Thermo Scientific Open Biosystems), and 
the bovine growth hormone polyA sequence from pPyCAG-BstXI-IP, was constructed 
by inserting these sequences at the SalI and NotI sites of pENTR-1A (Invitrogen). In 
addition the Puro-resistance gene cassette (pPGK-PuroR-poly A) flanked by FRT 
sequences was inserted at the EcoRV site of the vector. The resulting expression 
vector (pENTR-1A_CAG-nuc-3×mKate2-WPRE-PuroR) was then mixed with the 
ROSA26 targeting vector (Abe et al., 2011), which contains the Reading Frame 
Cassette B from the Gateway Conversion System (Invitrogen) at the KpnI and AscI 
sites, to perform the LR recombination reaction using the Gateway system. In the 
resulting targeting vector, the insertion cassette was in the same orientation as the 
ROSA26 gene. The targeting vector was purified and introduced into HK3i C57BL/6 
mouse embryonic stem (ES) cells as described previously (Kiyonari et al., 2010) with 
some modification, and the homologous recombined, puro-resistant ES cell clones 
were isolated for further culture and expansion. An aliquot of the cells was lysed and 
screened for successful homologous recombination by PCR. The integrity of the 
targeted region was confirmed by PCR using primers annealing outside the 
homologous recombination arms and within the inserted cassette. The primers used 
for the screening and the confirmation of genome integrity were as follows: 1) forward 
primer annealing to the region upstream of the 5' homologous arm: 
5’-TGCTGGCCTACTGCTGCCTCGATCTTAC-3’, 2) reverse primer annealing to the 
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region downstream of the 5' homologous arm: 
5’-AGGACAACGCCCACACACCAGGTTAGC-3’, 3) forward primer annealing to the 
region upstream of the 3' homologous arm: 
5’-CGTGGTGGAGCCGTTCTGTGAGACA-3’, 4) reverse primer annealing to the 
region downstream of the 3' homologous arm: 
5’-GGTGAAATGCTTGACTCCTAGACTT-3’, 5) reverse primer annealing to the CAG 
promoter: 5’-CAGCCAGGCGGGCCATTTACCGTAAGTTAT-3’, and 6) forward 
primer annealing to the poly-A region of the puro-resistance gene: 
5’-TCCATCAGAAGCTGGTCGATC-3’. The copy number of the inserted cassette 
was confirmed with a quantitative PCR assay using primers annealing to the coding 
sequences of the puro-resistance gene (forward primer: 
5’-CTCGACATCGGCAAGGTGTG-3’, reverse primer: 
5’-GGCCTTCCATCTGTTGCTGC-3’), normalized to the amount of TATA-box binding 
protein gene amplification (forward primer: 5’-CCCCCTCTGCACTGAAATCA-3’, 
reverse primer: 5’-GTAGCAGCACAGAGCAAGCAA-3’) (Tsujino et al., 2013) using 
the SYBR Premix Ex Taq GC (Takara #RR071A) and the ABI PRISM 7900 (Applied 
Biosystems). The selected ES cell clones were injected into 8-cell-stage ICR embryos 
to generate ~100% ES cell-derived chimeras (Kiyonari et al., 2010). 
 We also used the R26-H2B-EGFP (CDB0238K) and R26-H2B-mCherry 
(CDB0239K) mouse strains (http://www.cdb.riken.jp/arg/reporter_mice.html) (Abe et 
al., 2011) and the Thy1-YFP-H transgenic mouse strain (Feng et al., 2000) to observe 
static fluorescent gene-expression patterns in whole-brain imaging (Figure 3, S3, S5 
and S7). 
 For the SCN immunostaining assay (Figure 4 and S4), R26-H2B-EGFP 
knock-in mice housed under 12 h:12 h light-dark conditions were sacrificed for 
fixation at ZT0 and ZT12. C57BL/6 wild-type mice or Cry1–/–, Cry2–/– mice (van der 
Horst et al., 1999) were adapted to light-dark conditions for over 2 weeks followed by 
maintenance under constant dark (DD) conditions. The sampling was performed after 
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24 h of exposure (CT12 of day-0 to CT12 of day-1) to DD conditions, at CT12 and 18 
of day-1, and at CT0 and 6 of day-2. Samples were obtained from multiple animals 
within 30 minutes. 
 To obtain fixed brains from these mice, each animal was anesthetized with an 
overdose of pentobarbital (>100 mg/kg, i. p.; Somnopentyl, Kyoritsu Seiyaku, Japan). 
The subject was transcardially perfused with PBS containing ~10 U/mL of heparin 
(Wako Pure Chemical Industries Ltd., Japan) to flush the blood vessels and followed 
by perfusion with 4% (w/v) paraformaldehyde (PFA) in PBS (pH 7.4) for fixation. The 
acrylamide-embedded brain sample of CLARITY protocol was prepared as described 
previously (Chung et al., 2013). 
 The Arc-dVenus transgenic mice (line D) (Eguchi and Yamaguchi, 2009) were 
housed under DD conditions for about 2.5 days followed by 1500 lux of white light 
stimulation from CT2.5. After 5 h of the stimulation, the mice were sacrificed for 
fixation together with an unstimulated animal (Figure 6A). We conducted the light 
stimulation and sampling of multiple animals within ±30 minutes. For sampling, the 
mice were deeply anesthetized with ether. Then, the subject was transcardially 
perfused with PBS containing 5 U/mL of heparin (Wako Pure Chemical Industries Ltd., 
Japan) to flush the blood vessels and followed by perfusion with 4% (w/v) PFA in 0.1 
M PB (pH 7.4) for fixation. 
 Each excised brain was post-fixed with the same fixation solution for 18 to 24 h 
at 4°C. The fixed brain was immersed in 20% (w/v) sucrose in PBS at 4°C to remove 
PFA and for the following cryopreservation. If necessary, the sample was stocked in 
O.C.T. compound (Sakura Finetek, Japan) at –80°C until use. When the frozen 
sample was used for CUBIC protocol, it was thawed and washed with PBS and then 
immersed in CUBIC reagents. Note that the freezing step is merely for stocking 
samples and not compulsory. 
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 All experimental procedures and housing conditions were approved by the 
Animal Care and Use Committee of the RIKEN Kobe Institute or by the Gifu 
University Animal Experiment Committee, and all of the animals were cared for and 
treated humanely in accordance with the Institutional Guidelines for Experiments 
using animals. All mouse strains were maintained by crossing onto a C57BL/6 
background. 
 
Marmoset 
We studied a newborn infant marmoset at the age of three days, an offspring of a 
breeding pair aged three and four years. The animals were housed in home cages 
measuring 1670 × 610 × 620 mm under 12 h:12 h light-dark conditions (light: 
08:00–20:00). Each cage had four wooden perches, a food tray, and an automatic 
water dispenser. Animals were fed twice a day with solid food (CMS-1, CLEA Japan, 
Inc., Tokyo, Japan) soaked in water, mixed with suitable amounts of powdered milk 
formula, honey, gluconic acid calcium, vitamin C, and lactobacillus probiotic. In 
addition, their diet was supplemented with chopped boiled eggs or bananas once a 
week. Water was provided ad libitum. For fixed brain sampling, the three-day-old 
marmoset was anesthetized with an overdose of pentobarbital (40 mg/kg, i.p.; 
Somnopentyl, Kyoritsu Seiyaku, Japan) after an intramuscular injection of ketamine 
(30 mg/kg; Ketalar, Daiichi Sankyo Propharma, Japan). The subject was 
transcardially perfused with PBS containing ~10 U/mL heparin (Wako Pure Chemical 
Industries Ltd., Japan) to flush the blood vessels and followed by perfusion with 4% 
(w/v) PFA in PBS (pH 7.4) for fixation. The excised brain was post-fixed with the 
same solution for 18 to 24 h at 4°C. The fixed brain was immersed in 20% (w/v) 
sucrose in PBS at 4°C and finally stocked in O.C.T. compound (Sakura Finetek, 
Japan) at –80°C until use. Animals were maintained and handled in accordance with 
the recommendations of the United States National Institutes of Health, and all 
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procedures were approved by the Animal Care and Use Committee of the RIKEN 
Kobe Institute. 
 
Chemical screening 
The usage of one fixed whole brain per one chemical compound (or one chemical 
configuration) is not desirable for first chemical screening because it is 
time-consuming, labor-intensive and even unethical to prepare numbers of fixed 
mouse brains to test many chemical configurations. Therefore, we developed a new 
evaluation protocol, in which we exchanged the order of fixation and isolation, and 
also introduced homogenization processes (chopping and sonication) in order to test 
many chemical configurations using only one mouse brain. An adult mouse brain was 
removed from the skull, chopped with a blade, suspended and sonicated in PBS, and 
gradually mixed with 8% (w/v) PFA in PBS (pH 7.4). The resulting fixed brain 
suspension was washed with PBS several times and finally used for the solubilization 
assay in Figure 1A and 1B to evaluated the clearing efficiency of each cocktail. The 
suspension was centrifuged to remove PBS, and re-suspended in candidate chemical 
solutions (10 wt% in water) followed by 24 h of incubation at room temperature. The 
OD600 of the incubated mixture was measured with the PowerWave XS and the 
attached operation software (Bio-Tek). The relative OD600s were calculated by fitting 
to a standard curve generated by diluting several concentrated mixtures of the 
suspension in PBS. The relative transmittance value of each sample (defined as 
100% minus the relative OD600) was qualitatively consistent with the expected 
brain-clearing capability (Figure 1A, graph of the right panel). The chemical solutions 
were also mixed with recombinant EGFP (0.1 mg/mL, final concentration) and 
incubated for 12 h at room temperature, and the resulting fluorescent signals were 
measured with the ARVO MX (PerkinElmer, USA). The values of the chemical 
solutions (without the fluorescent protein) were also measured and subtracted as the 
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background signal. Relative fluorescence was calculated by normalization with an 
EGFP sample that was mixed and incubated with PBS, and titrated to show linearity. 
All data were calculated as an average of duplicated measurements, and two 
independent experiments were performed (Figure 1B and C). The chemicals were 
also assayed for their effects on the fluorescence of EYFP, mCherry (0.1 mg/mL, final 
concentration) and mKate2 (0.05 mg/mL, final concentration) in addition to EGFP in 
Figure 2C, but are shown as raw fluorescent values. To prepare the recombinant 
fluorescent proteins, the genes encoding them (containing a His-tag at the 
N-terminus) were cloned into pET15b (Merck Millipore) and transformed into the E. 
coli BL21/DE3 strain. Overexpressed proteins were purified with Ni-NTA agarose 
(Qiagen) according to the manufacturer's instructions. The refractive indices of the 
solutions in the chemical screening were measured by an Abbe refractometer 
(ATAGO, DR-A1, Japan).  
We have developed improved brain tissue clearing reagents by 
comprehensive chemical screening described above. During the screening process, 
we followed the principle that brain clearing reagents should be developed that: a) 
minimize light scattering in the sample by adjusting the inner RI to approximately 1.5, 
and b) preserve the signals from fluorescent proteins and antibodies to visualize 
functional activities and obtain structural information. Since hydrophobic lipids are a 
major source of light scattering in the fixed brain, the removal and/or solvation of 
lipids using hydrophobic reagents has traditionally been used to transparentize the 
brain. The classic BABB protocol involves an initial dehydration step with ethanol 
followed by an RI-adjustment step with benzyl alcohol:benzyl benzoate (1:2 ratio), 
resulting in transparent brain specimens. However, both steps suppress EGFP 
fluorescence (Hama et al., 2011). Among hydrophobic organic chemicals, the use of 
THF as a dehydrant and DBE as an RI-adjusting medium increased the preservation 
of EGFP fluorescence with improved tissue transparency (Becker et al., 2012). 
However, EYFP fluorescence was still significantly quenched by DBE (Erturk et al., 
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2012; Ke et al., 2013). Thus, it may be intrinsically difficult for hydrophobic media to 
provide efficient clearing with fluorescence signal preservation. In contrast, Scale was 
developed based on water-soluble clearing reagents (Hama et al., 2011; Ke et al., 
2013). Scale contains kosmotropic glycerol (which stabilizes intermolecular 
interactions) and chaotropic urea (which disturbs hydrogen networks) as 
hydration-promoting agents. Since Scale promotes the optical clearing of brain 
specimens despite its relatively low RI (1.38), the chemicals in Scale may permeate 
the brain tissue efficiently. Scale also preserves the signals of fluorescent proteins. 
The original Scale protocol (e.g. ScaleA2) is suitable for clearing fetal mouse brains, 
but has drawbacks such as a long incubation time and sample swelling (Ke et al., 
2013). Another hydrophilic clearing reagent, SeeDB, a highly concentrated fructose 
aqueous solution that functions as an RI-adjusting medium, overcomes these issues 
(Ke et al., 2013). Brain specimens treated with SeeDB are transparentized within a 
few days, and do not show sample expansion. These features are partly due to 
SeeDB’s high RI and osmotic pressure, which leads to the exclusion of water 
molecules and the permeation of fructose molecules. However, highly myelinized 
adult brain samples treated with these hydrophilic reagents were not sufficiently 
transparent for observation using rapid whole-brain imaging with LSFM. Thus, while 
the hydration-promoting and hydrophilic clearing reagents were effective in some 
cases, improvements were needed to increase their applicability. Although it may be 
difficult to promote dehydration with water-soluble chemicals, the simultaneous 
improvements in dehydration and RI homogenization by a highly osmotic and 
RI-aqueous medium like SeeDB was a promising approach. Based on these previous 
findings, we sought to develop a simple and efficient tissue-clearing protocol. 
We used a comprehensive chemical screening approach to gain insight into 
the chemical mechanisms that contribute to effective clearing. Our improved strategy 
reduced the number of mice required and facilitated the quantitative evaluation of a 
reagent’s clearing ability by measuring the transparency of a homogenized 
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suspension instead of a whole brain. Although polyhydric alcohols including glycerol 
have traditionally been used, their clearing ability against hydrophobic lipids and 
proteins had not been quantitatively evaluated. Unexpectedly, #18 glycerol and other 
hydrocarbon polyols [except #11 1,4-bis(2-hydroxyethoxy)-2-butyne] did not cause a 
significant increase in the transparency of brain suspension in our experiment (Figure 
1B). In contrast, our screening revealed that a series of aminoalcohols 
transparentized the suspension quite efficiently. Positively charged amino groups 
may contribute to the neutralization of negatively charged phospholipids, which are 
the most abundant lipids in the brain (Morell and Quarles, 1999). As expected, all of 
the tested detergents were relatively effective in clearing the suspension. 
2-amino-1,3-propanediol (#15) in the alcohol category was rejected due to its cost 
and safety concerns (see also Supplemental Table S1). Among them, the non-ionic 
detergents (except for a specific TritonX-100) quenched the EGFP fluorescence 
(Figure 1C). Deoxycholate was the best candidate for clearing detergents in the first 
screening, but led to EGFP quenching in the presence of aminoalcohol and urea. 
Chaotropic agents such as urea are well-known surfactants that disrupt non-covalent 
interactions such as protein-protein, protein-lipid, and lipid-lipid associations. Urea 
has been shown to clear brain tissue effectively (Hama et al., 2011), although the 
chemical mechanism is poorly understood. We further investigated the clearing ability 
of urea-related chemicals such as aprotic solvents without amide, urea-like amides, 
and other chaotropic agents. Aprotic solvents without amide (#31 acetonitrile, #39 
dimethylsulfoxide, and #40 1,4-dioxane) and urea-like amides (#29 
N,N-dimethylacetamide and #30 N,N-dimethylformamide) did not significantly clear 
the suspension. Other urea-like amides (#32 oxamide, #34 N-carboxymethylurea, 
and #37 biuret) were difficult to dissolve in water. Among the chaotropic agents, #38 
thiourea caused higher transparency than #36 urea, while #33 guanidine 
hydrochloride did not clear the suspension. Our chemical screenings in this study and 
the previous work on Scale indicated that urea’s chemical structure and chaotropic 
ability would contribute to the efficient clearing of brain tissues. Taking into account 
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the heterogeneity of the biochemical components in the brain, we prepared 
reagent-1, which consisted of aminoalcohol, Triton X-100 and urea, analogous to the 
components in ScaleA2 reagents (Figure S1B). Another urea-like molecule, 
formamide, can be also used for tissue-clearing as indicated in the recent study 
(ClearT) (Kuwajima et al., 2013). Comparison between urea and formamide in the 
CUBIC protocol will be a subject of future investigation. 
Reagent-1 treatment of the whole mouse brain resulted in a highly 
transparent sample (Figure 2A). The lipid-rich white matter was not completely 
cleared, however, suggesting that lipid removal was incomplete and that the RIs of 
the reagent and the sample were imperfectly matched. We sought to identify 
additional reagents that might increase brain tissue transparency through RI 
adjustment. As a solute’s concentration increases, the osmotic pressure and RI 
increase simultaneously. Thus, large water-soluble molecules such as sugars are 
excellent candidates for solutes that will yield high-RI solutions. Fructose is one of the 
most water-soluble solutes, but aminoalcohols obtained from our screening would 
react with the aldehyde group of fructose, resulting in a brownish color via the 
Maillard reaction. Thus, sucrose was selected instead. Previous studies used a 60% 
sucrose aqueous solution for brain clearing (Tsai et al., 2009), but the clearing 
efficiency was much lower than for Scale or SeeDB (Hama et al., 2011; Ke et al., 
2013). We prepared a highly osmotic, high-RI solution, reagent-2 (RI = 1.48-1.49), by 
mixing concentrated sucrose with cocktails based on the reagent-1 composition. 
When reagent-1-treated brain samples were then subjected to reagent-2, deeper 
regions of the brain, including the dense lipidic myelin sheath were transparentized 
(Figure 2A). In addition, sample swelling was minimized because the permeation of 
chemicals into the tissue was balanced by osmotic dehydration during reagent-2 
treatment. The combination of reagent-1, Scale-inspired chemicals that promote 
tissue permeation, and reagent-2, a highly osmotic, high-RI aqueous reagent that 
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promotes RI-homogenizing dehydration, resulted in improved clearing of the adult 
mouse whole brain without denaturing fluorescent proteins and antibodies.  
 
Measurement of light transmittance 
Brain sample transmittance was measured with the CM-5 spectrophotometer 
(Konica-Minolta, Japan). For this, 100% transmittance was calibrated with a 5 × 10 
mm slit, and samples were placed on a 5 × 2 mm slit for measurement. The blank 
value was measured as the transmittance of the latter slit without the dish and sample. 
Each value was determined as an average of duplicate measurements. The 
ventral-to-dorsal transmittance of the central part of the whole brain immersed in the 
indicated reagents was measured for Figure 2B. The central-to-lateral transmittance 
of the thickest part of a hemisphere placed on a plastic bottom dish without liquid was 
measured for Figure 1E and S1A, to make the procedure easier and avoid difficulties 
cementing samples to the dish. As a result, some of the measured values exceeded 
100%, which we speculate is a consequence of the hemisphere acting as a convex 
lens because of the mismatch in RI between the air and the CUBIC samples. In this 
case, the values are notated as relative values (A.U.) rather than % transmittance. 
 
The CUBIC protocol 
ScaleCUBIC-1 (reagent-1) was prepared as a mixture of 25 wt% urea (Nacalai 
Tesque Inc., 35904-45, Japan), 25 wt% 
N,N,N',N'-tetrakis(2-hydroxypropyl)ethylenediamine (Tokyo Chemical Industry CO., 
LTD., T0781, Japan), and 15 wt% polyethylene glycol mono-p-isooctylphenyl 
ether/Triton X-100 (Nacalai Tesque Inc., 25987-85, Japan). Some technical tips 
regarding reagent-1 preparation are as follows: 1) 
N,N,N',N'-tetrakis(2-hydroxypropyl)ethylenediamine is a highly viscous liquid and can 
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be used as an 80 wt% working solution. 2) The quality of Triton X-100 product seems 
critical for preserving fluorescent signals and we highly recommend the product 
indicated above. When the same chemical from other vendors is used, the quenching 
effect on recombinant fluorescent proteins should be checked. ScaleCUBIC-2 
(reagent-2) was prepared as a mixture of 50 wt% sucrose (Nacalai Tesque Inc., 
30403-55, Japan), 25 wt% urea, 10 wt% 2,2',2''-nitrilotriethanol (Wako Pure Chemical 
Industries Ltd., 145-05605, Japan), and 0.1% (v/v) Triton X-100. We referred the 
concentration of urea in ScaleA2 (4 M) (Hama et al., 2011), for determining its 
concentration in CUBIC reagents (25 wt%). Other components were added as much 
as possible, considering fluorescent signals and viscosity. Both reagent-1 and -2 
were prepared just prior to use. When mixed, a hot stirrer should be used except 
during the addition of Triton X-100. Because water evaporation will make it difficult for 
the highly concentrated chemicals to dissolve, the weight should be monitored 
frequently for the addition of evaporated water during the mixing step. After 
confirming that all the mixed chemicals are dissolved, the reagents are cooled to 
room temperature, and finally Triton X-100 is added. Both CUBIC reagents should be 
degassed before use. 
 For whole-brain clearing, fixed brain samples were immersed in reagent-1 (10 g 
per brain) at 37°C for 3 days with gentle shaking. The solution was then exchanged, 
and the brain was immersed for an additional 3 to 4 days. At that point, if the white 
matter is not significantly cleared, further immersion with exchanged reagent-1 may 
be needed. The treated brain was washed with PBS several times at room 
temperature with gentle shaking, immersed in 20% (w/v) sucrose in PBS, degassed 
(required to prevent air bubbles from remaining in the ventricle), and immersed in 
reagent-2 (10 g per brain) for 2 to 7 days. Further immersion increased the final 
transparency but also caused swelling of the sample. After imaging, the sample was 
again washed with PBS, immersed in 20% (w/v) sucrose in PBS, and stocked in 
O.C.T. compound at –80°C. For nuclear staining with SYTO 16 (Life Technologies), 
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0.25 to 2 µM of the stain (depending on sample size) was added during reagent-1 
treatment. For nuclear staining with propidium iodide (PI, Life Technologies), 10 
µg/mL of the stain was added during reagent-1 treatment. After the step, additional 
staining was needed: sample was further incubated in 10 µg/mL of PI/PBS for 3 days 
at 37°C with rotation. Then, the solution was exchanged followed by staining for an 
additional 3 days. 
 
3D-immunostaining of CUBIC samples 
A fixed brain block was treated with reagent-1 for 3 to 6 days, washed with PBS, 
immersed in 20% (w/v) sucrose in PBS, and frozen in O.C.T. compound at –80°C 
overnight. The frozen sample was then thawed, washed with PBS, and subjected to 
immunostaining with the primary antibodies in 750 µL of 0.1% (v/v) Triton X-100, 
0.5% (w/v) bovine serum albumin, 0.01% (w/v) sodium azide in PBS for 3 days at 
37°C with rotation. The stained samples were then washed with 10 mL of 0.1% (v/v) 
Triton X-100 in PBS several times at 37°C with rotation and then stained with the 
secondary antibodies in 750 µL of 0.1% (v/v) Triton X-100, 0.1% (w/v) bovine serum 
albumin, 0.01% (w/v) sodium azide in PBS for 3 days at 37°C with rotation. The 
stained samples were then washed with 10 mL of 0.1% (v/v) Triton X-100 in PBS 
several times at 37°C with rotation, immersed in 20% (w/v) sucrose in PBS, degassed, 
and immersed in reagent-2 for 24 to 36 hours. Note that longer treatment with 
reagent-2 may cause nonspecific signals in the void structures such as vessels and 
ventricles. The following antibodies were used for the staining: rabbit anti-VIP 
(Immunostar 20077, 1:300), goat anti-Copeptin (Santa Cruz Biotechnology Inc. 
sc-7812, 1:100), rabbit anti-Synapsin I (Millipore AB1543P, 1:250), donkey anti-rabbit 
Alexa 647 and anti-goat Alexa 546 (Life Technologies, 1:750 each). These antibodies 
were mixed with the sample after filtration with an Ultrafree-MC GV Centrifugal Filter 
(Millipore UFC30GV00). We have succeeded in the efficient 3D-IHC of all antibodies 
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in our study. Although we have not yet encountered less effective antibodies, we 
could not exclude the possibility of impaired immunostaining resulting from the urea 
denaturation. The most important point may be that the antibodies are polyclonal. 
Also, peptide antibodies such as rabbit anti-VIP and goat anti-Copeptin would 
minimize the urea denaturation effect. On the other hand, in case of the antibodies 
recognizing a specific protein conformation, the urea denaturation may critically 
inhibit the antigen-antibody reaction. In our protocol, the fixed hypothalamus block 
was incubated in the antibody cocktail for 3 days at 37°C. In Figure 4C and the right 
panel of Figure S4C, we found that AVP immunoreactive signal was observed in the 
depth of at least 800 µm. Therefore, the kinetics of penetration can be conservatively 
estimated at ~270 µm/day at 37°C. Although VIP signal was not observed in the 
depth of 750 µm, the result was consistent with previous reports that VIP fibers were 
terminated around the subparaventricular region (Abrahamson and Moore, 2001). 
 
Microscopy 
Whole-brain fluorescence images were acquired with light-sheet fluorescence 
microscopy (LSFM) (Ultramicroscope, LaVision BioTec, Germany), combined with 
488 nm and 588 nm lasers (Coherent Sapphire488LP-100 and Sapphire588LP-50), a 
sCMOS camera (Andor Neo 5.5) and a macrozoom microscope (Olympus 
MVX-ZB10) with 0.63× objective lens (Olympus MVPLAPO0.63X, NA = 0.15, working 
distance = 87 mm) (Figure S3A). The camera and the microscope were connected to 
a camera adaptor (Olympus MVX-TV1X), tube lens (Olympus MVX-TLU), and the 
Ultramicroscope filter wheel unit (LaVision BioTec, emission filters: ET525/50 and 
ET650/60), with adaptors (LaVision BioTec, LV AD MVX_1 and LV AD MVX_2). 
Samples were immersed in a 1:1 mixture of silicon oil TSF4300 (Momentive 
Performance Materials Inc., RI = 1.498) and mineral oil (Sigma-Aldrich, RI = 1.467) 
during image acquisition. Images were captured using 2× zoom (for mouse brain) and 
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1× zoom (for marmoset brain) with the MVX-ZB10. When 2× zoom was used, the 
theoretical X-Y resolution of acquired image is about 4.7 µm. We prepared a 
customized sample holder for capturing the image of a larger marmoset hemisphere 
and for easier sample handling. Each plane was illuminated from both the right and 
left sides, and a merged image was saved. The exposure times were adjusted 
according to the fluorescent signal intensities of each sample. We acquired 25 
whole-brain images in total (4× single-channel whole mouse brains taken from two 
directions, 4× two color-channels whole mouse brains taken from two directions, 1× 
single-channel marmoset hemisphere taken from one direction) for this study. 
We quantified the level of background fluorescence in CUBIC samples 
(Figure 3F, 3G, 3H, and 3I). For the analysis, we used images from the 
R26-pCAG-nuc-3×mKate2 mouse brain. First, we masked the regions outside the 
brain to precisely evaluate the background fluorescence inside the brain. To this end, 
we constructed the 3D NIfTI-1 image file for this brain and aligned the 
Waxholm-Space atlas (i.e. reference brain) to the brain. We then created a binary 
mask using the aligned atlas and applied it to the raw TIFF images so that all pixels 
that are not in an annotated region (i.e. pixels that fall outside the brain) have their 
intensity set to zero. We used pixels with non-zero value (i.e. inside the brain) of the 
resulting images for the subsequent analysis. This dataset includes 646 horizontal 
slices, numbered from 0, so we then worked on slice 322, at the center of the brain 
(Figure 3F, left panel). Our initial step was to manually determine two thresholds that 
separate the low-intensity signal (smaller than 8100), medium-intensity signal 
(between 8100 and 35000) and high-intensity signal (greater than 35000). This was 
obtained by extracting these regions from the raw image (left), normalizing the three 
resulting images and assigning each to a channel of the false-color RGB image. We 
color-coded these signals in blue, green and red, respectively (Figure 3F, middle 
panel). This identifies very distinct regions, and background fluorescence is in the 
blue region, and appears well-below the signal of interest, in the green and red 
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regions. This is confirmed in the right panel of Figure 3F, where all pixels with an 
intensity below 8100 are set to black. The background is visibly removed, while the 
real fluorescence signal is unaffected. To obtain more reliable background 
fluorescence levels while avoiding edge effects, we extended this result to slices 
161-483 (50% of the total data). The background fluorescence level was associated 
with a peak in the low-intensity region of the image histogram, shown in Figure 3G for 
three slices (161, 322 and 483). For example, the peak of the background 
fluorescence is at intensity 7,616 for slice 322. Based on these histograms and on 
Figure 3F, we estimated that most background pixels have an intensity no more than 
5% higher than this peak intensity (7616+5%=7996.8). We therefore used this 
threshold (5% higher than the background peak), and considered intensity above this 
threshold as signals (e.g. 50th percentile of the signal intensity corresponds the 
median intensity for pixels between this threshold and the maximum intensity). We 
repeated this analysis for other slices 161-483, and showed 95th, 80th, 65th, and 50th 
percentile of the signal intensity as well as the peak intensity of the background 
fluorescence in Figure 3H. We also calculated the ratio between each percentile of 
the signal intensity and the peak intensity of the background fluorescence (Figure 3I), 
which indicates that the fluorescence signal is significantly brighter than the 
background peak. 
 Immunostained SCN and cerebral cortex images were acquired with an 
inverted confocal microscope (Leica TCS SP8) with 10× (Leica PL APO CS, NA = 
0.40, working distance = 2.2 mm) or 20× (Leica PL APO CS2, NA = 0.75, working 
distance = 0.68 mm) objective lenses, and with another inverted confocal microscope 
(Carl Zeiss LSM700) with a 10× (Plan Apochromat, NA = 0.45, working distance = 2.1 
mm) objective lens. To detect most of the stained signals in the unsaturated range of 
intensity, laser output was gradually increased according to the Z-stack acquisition. 
 Arc-dVenus Tg brain images in Figure S6A were captured with 
fluorescence stereomicroscopy using the same settings as previously described 
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(Eguchi and Yamaguchi, 2009). Two-photon imaging was performed using an upright 
multiphoton microscope (Olympus FV1000, BX61WI) combined with a MaiTai 
DeepSee HP-OL laser (Spectra Physics) and a 25× objective lens for Scale (Olympus, 
XLSLPLN25XSVMP, NA = 0.9, working distance = 8 mm) for Figure 2D and S2, or 
using another upright multiphoton microscope (LSM7MP, Carl Zeiss) combined with a 
MaiTai DeepSee laser (Spectra Physics) and a 25× objective lens (Olympus 
XLPLN25XWMP, NA = 1.05, WD = 2 mm) for Figure S5B. 
 
Image data processing 
All raw image data were collected in a lossless TIFF format (16-bit images for LSFM 
and two-photon microscopy data, and 8-bit images for confocal microscopy data). 
3D-rendered images were visualized and captured with Imaris software (version 7.6.4, 
Bitplane). Brightness, contrast, and gamma of the 3D-rendered images were 
manually adjusted with the software at minimum when visualized. Confocal and 
two-photon 2D images as well as a projection image of Thy1-YFP-H brain (Figure 
S5A) were processed and visualized with Fiji (http://fiji.sc/Fiji). Z-projection (maximum 
intensity) was performed to stack 2 to 21 sequential images with the software. 
Brightness and contrast were manually adjusted at minimum when visualized. 
Gaussian filtering was performed on the image in Figure S5B. 
 To facilitate the dissemination of neuroinformatics tools, the Neuroimaging 
Informatics Technology Initiative (NIfTI) introduced the NIfTI-1 data format (.nii 
extension), which is now supported by most major software packages. Detailed 
specifications are available on the Initiative’s website: http://nifti.nimh.nih.gov/nifti-1/. 
The computational analysis described below relies on this format. NIfTI-1 files were 
visualized using ITK-SNAP (Yushkevich et al., 2006) (Figure 7 and S7). 
 24 
 To generate a NIfTI-1 file from each stack of TIFF images obtained from LSFM, 
we first converted the images to 16-bit PNG files using ImageMagick. During this 
conversion, we also downscaled to 25% (i.e. keeping one of every four images and 
changing the resolution of these images from 2560×2160 to 640×540). This was 
necessary because of memory limitations of the current software tools. Using the 
Convert3D tool from ITK-SNAP, each temporary stack was converted to a NIfTI-1 file, 
specifying the correct spacing (0.02064×0.02064×0.04 mm, given the downscaling) 
and the correct orientation (which depended on the acquisition direction). Each 
resulting NIfTI-1 file was visualized and manually checked for size and orientation. 
These NIfTI-1 files were the input for the subsequent computational analysis. 
 The reference atlas used in our analysis was the Waxholm Space Atlas 
(Johnson et al., 2010). The Canon T1 image was downloaded from the website of the 
International Neuroinformatics Coordinating Facility: 
http://software.incf.org/software/waxholm-space, and downscaled to 216×512×256 
(again for memory concerns in subsequent steps). Spacing was adjusted accordingly. 
To remove surrounding non-brain tissue, this image was then multiplied by a binary 
mask calculated from the WHS annotation labels (using Convert3D), so that only 
labeled areas, (i.e., only brain regions), were conserved in the atlas NIfTI-1 file used 
for registration, as detailed below. 
 
The CUBIC informatics 
To facilitate analysis across samples, whole-brain images are registered and aligned 
to reference structures. In our analysis, we aligned images by pairs, in which one 
image corresponded to the structural information (obtained via nuclear staining) and 
the other to the signal channel. For each pair, we performed two steps: (i) registration 
of the structural information to a reference, and (ii) alignment of both images, i.e., 
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applying the transformation (calculated during the registration) to both the structural 
image and the signal channel image (Figure 7A). 
Image registration is a very active field of research, (see e.g. (Avants et al., 
2011; Woods et al., 1992)). Here, we use ANTs (Advanced Normalization Tools), 
which has proved successful in a number of image registration tasks (Murphy et al., 
2011). When aligning our composite images with each other or to the Waxholm 
Space Atlas, we use affine transformations only (with mutual information, 64 bins and 
300000 samples as the parameters of the ANTS function). When aligning images of 
the same brain obtained from opposite acquisition directions, as part of the image 
composition process, we allowed small nonlinear transformations to overcome 
differences in sharpness. These nonlinear transformations were calculated in ANTs 
using SyN, the symmetric normalization model (Avants et al., 2008; Klein et al., 
2009). The affine parameters were unchanged, and we used 10×10×10 iterations for 
SyN. One file was generated for each transformation. Nonlinear transformations are 
not compulsory: it is also possible to use affine transformations only for this step. The 
results shown in Figure 7 did not use SyN. Finally, alignment was performed using 
the WarpImageMultiTransform function and the computed transformations above as 
parameters (i.e., the affine transformation if using affine registration only, or both the 
affine transformation and the diffeomorphic transformation otherwise). 
The overall analysis process is summarized in Figure S7A. We first aligned 
and combined images of the same brain acquired from opposite directions. We then 
aligned these composite images to an internal reference and to the Waxholm Space 
Atlas. Finally, we compared the signal channel images of different brains, e.g. by 
subtracting them [using the fslmaths function from FSL (Jenkinson et al., 2012)] to 
highlight differences in expression in specific regions (Figures 7D and 7E).  
When images from two acquisition directions were available for the same 
brain, combining them into a single composite 3D image ensured optimal sharpness 
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of the 3D image throughout the brain. This was motivated by the fact that, in images 
taken in the ventral-to-dorsal (V-D) direction, the ventral horizontal slices were 
sharper, while in images taken in the dorsal-to-ventral (D-V) direction, the dorsal 
horizontal slices were sharper, (Figure S7C). When comparing two images of the 
same object, the image with more edges can be considered sharper. We therefore 
estimated via the Sobel operator (Gonzalez and Woods, 2002) the “edge content” of 
each horizontal plane of the D-V and V-D 3D images of the same brain. This 
operation defined two unique values, n  and m , such that the relative difference in 
“edge content” was below 10% for planes between n  and m , (Figure S7D). We 
respectively noted VDiS  and 
DV
iS , the horizontal slice number i  from the V-D image 
and the D-V image previously aligned to the V-D image. We could then construct the 
composite 3D image, one horizontal slice at a time, with the weighted sum 
VD
i
DV
i
COMP
i SwSwS ×−+×= )1(  and weights w  defined as follows: 0=w  if ni ≤ , 
1=w  if mi ≥  and mn
n
nm
iw −+−=  otherwise. The resulting image was sharp 
throughout the brain, (Figure S7E). We implemented the operator and the weighted 
sum to operate on matrices containing raw intensity values. To obtain these values 
from the NIfTI-1 files, and then to export the results back to the NIfTI-1 format, we 
used the FSL functions fsl2ascii and fslascii2img, respectively. 
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